Cooley Advises Underwriters on TriVascular IPO

San Francisco, Calif. – April 23, 2014 – Cooley LLP announced today that it advised the underwriters on TriVascular Technologies, Inc.'s initial public offering. TriVascular is a medical device company that develops and commercializes innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. It now trades on the NASDAQ Global Stock Market under the symbol "TRIV."

J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC acted as joint book-running managers for the offering. Canaccord Genuity Inc. and Stifel, Nicolaus & Company, Incorporated acted as co-managers.

The Cooley corporate and securities team advising the underwriters was led by partners Charlie Kim, Drew Williamson and David Peinsipp, and included associates Jonie Kondracki, Veer Bhavnagri, Robert E. Jones and Joe Sexton. Critical support for the offering was provided by partner Scott Talbot and associates Scott Weston and Ariana Hiscott (intellectual property); partners Natasha Leskovsek and Wendy Goldstein, special counsel Phil Mitchell and associate Jennifer Shanley (regulatory); partners Danish Hamid and Kevin King (FCPA and OFAC); partner Renee Deming and associate Sarah Dale (compensation & benefits); and partner Susan Philpot (tax).
 
Year-to-date in 2014, Cooley has advised on 47 completed public offerings, including 24 completed IPOs.

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.

Cooley has more than 750 lawyers across 11 offices in the United States and China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may have been generated with the assistance of artificial intelligence (AI) in accordance with our AI Principles, may be considered Attorney Advertising and is subject to our legal notices.